“…Still in the laboratory context, in addition to the food area, this biotechnology has been explored in clinical and pharmacological issues, as a promising technique in the search for biological routes in the identification of pathogenic microorganisms in exams (SOUZA; COBERLLINI, 2019) or playing a role as a method of obtaining metabolites that may act as potential new drugs, such as, for example, in the biotransformation processes of antiasthmatic drugs (AHMAD et al, 2014), anthelmintics (BARTH et al, 2015), antidepressants (OLIVEIRA et al, 2015(OLIVEIRA et al, ) al., 2015 or compounds with antimicrobial activity (GRABARCZYK et al, 2013). This biotechnology has also been linked to genetic and biochemical issues, evaluating the alterations that secondary metabolites, dispersed in the environment, It must be mentioned that concomitant biotransformation has also been addressed at the intersection of activities in the food industry and industrial innovations.…”